Paratek Pharma Inc
(PRTK)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 39,993 | 31,236 | 75,557 | 30,213 | 29,637 |
| Cost of Goods | 4,368 | 6,244 | 10,312 | 4,372 | 4,878 |
| Gross Profit | 35,625 | 24,992 | 65,245 | 25,841 | 24,759 |
| Operating Expenses | 45,404 | 41,041 | 68,394 | 42,704 | 38,805 |
| Operating Income | -9,411 | -15,805 | -2,837 | -16,491 | -13,168 |
| Interest Expense | 5,287 | 4,476 | 4,558 | 4,536 | 4,546 |
| Other Income | 196 | 199 | 295 | 147 | 95 |
| Pre-tax Income | -14,502 | -20,082 | -7,100 | -20,880 | -17,619 |
| Income Tax | 51 | 61 | N/A | N/A | N/A |
| Net Income Continuous | -14,553 | -20,143 | -7,157 | -20,880 | -17,619 |
| Net Income | $-14,553 | $-20,143 | $-7,157 | $-20,880 | $-17,619 |
| EPS Basic Total Ops | -0.25 | -0.35 | -0.11 | -0.38 | -0.33 |
| EPS Basic Continuous Ops | -0.25 | -0.35 | -0.11 | -0.38 | -0.33 |
| EPS Diluted Total Ops | -0.25 | -0.35 | -0.11 | -0.38 | -0.33 |
| EPS Diluted Continuous Ops | -0.25 | -0.35 | -0.11 | -0.38 | -0.33 |
| EPS Diluted Before Non-Recurring Items | -0.25 | -0.35 | -0.12 | -0.38 | -0.33 |
| EBITDA(a) | $-9,365 | $-15,758 | $-2,751 | $-16,362 | $-13,037 |